Notice of Intent to Sole Source- Georgia Drug and Narcotics Agency (GDNA)

The Food and Drug Administration (FDA) issued this special notice of intent to award a sole-source contract for investigative services to the Georgia Drug and Narcotics Agency (GDNA). This acquisition is conducted under the authority of 10 U.S.C. 2304(c)(5) to provide professional support for a twelve-month performance period beginning from the date of award. The work is classified under NAICS 922120 for Police Protection and PSC R499 for Support- Professional: Other. There is no set-aside designated for this requirement.

The primary place of performance is Atlanta, Georgia. While this notice does not constitute a request for competitive proposals, the government will consider capability statements from interested parties to determine if a competitive procurement is warranted. All responses are due by April 3, 2026, at 10:00 AM EST and must be submitted via email to the point of contact, Nina Montgomery.

The solicitation, identified as FDA-RFQ-26-133519, was published on March 31, 2026. Associated documentation includes one PDF attachment titled Notice of Intent_GA.pdf. The government maintains full discretion regarding the determination to compete the proposed action based on the feedback received during the response period.